Vault-13

EVOKE PHARMA INC EVOK

COM · Common Stock · CUSIP 30049G302

11 institutional holders +0 vs Q1 2025
232,022232.0k shares reported held*
$603.6kreported value*
1 new 2 added 1 reduced 1 sold out net sold ≈ $38.0k (-30.2k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.60.

Trends to Q2 2025

Institutional holders

Managers reporting a position, each quarter

051015Q3 24: 13Q4 24: 9Q1 25: 11Q2 25: 1111Q3 24Q4 24Q1 25Q2 25
Numbers
QuarterHolders
Q3 202413
Q4 20249
Q1 202511
Q2 202511

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
10010Q4 24: 2 bought or addedQ4 24: 6 cut or sold outQ4 24Q1 25: 4 bought or addedQ1 25: 2 cut or sold outQ1 25Q2 25: 3 bought or addedQ2 25: 2 cut or sold outQ2 25
Numbers
QuarterBought or addedCut or sold out
Q4 202426
Q1 202542
Q2 202532

Biggest buyers

Tower Research Capital LLC (TRC) Added +1,775+1.8k
FMR LLC New +301+301
BANK OF AMERICA CORP /DE/ Added +1+1

Biggest sellers

BRC Group Holdings, Inc. Sold out -20,000-20.0k
CITADEL ADVISORS LLC Reduced -12,261-12.3k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Klein Roger M. 13D · may seek influence new · filed 2025-11-12
Stated purposeOn November 4, 2025, Mr. Klein acquired, or in his capacity as trustee caused the Krieger Charitable Trust (the "Charitable Trust") to acquire, all 163,000 shares of Common Stock of the Issuer currently owned by the Reporting Persons (the "Klein Shares"). This acquisition came after the Issuer announced in a Current Report on Form 8-K (the "Merger 8-K") filed with the U.S. Securities and Exchange Commission on November 4, 2025, that on November 3, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger") with QOL Medical, LLC, a Delaware limited liability company ("Parent"), and certain of its affiliates (together with Parent, "QOL"), pursuant to which QOL will commence a tender offer (the "Offer") to acquire all of the outstanding shares of Common Stock for $11.00 in ca… Full filing
10.5% new 163.0k 2025-11-12

Fell to 5% or below in the last year: Nantahala Capital Management, LLC (0.0%, 2025-12-19), MORGAN STANLEY (0.0%, 2025-12-05)

Holders, Q2 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Nantahala Capital Management, LLC 0.03% of their portfolio NEW CANAAN, CT 148,153148.2k $385.2k $385.2k 0.03% Unchanged
2 Bleichroeder LP 0.04% of their portfolio NEW YORK, NY 68,75068.8k $178.8k $178.8k 0.04% Unchanged
3 CITADEL ADVISORS LLC 0.00% of their portfolio MIAMI, FL 12,54212.5k $33.0k $33.0k 0.00% Reduced -12.3k -12,261
4 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 1,9882.0k $5.2k $5.2k 0.00% Added +1.8k +1,775
5 FMR LLC 0.00% of their portfolio BOSTON, MA 301301 $792 $792 0.00% New
6 BlackRock, Inc. 0.00% of their portfolio New York, NY 122122 $317 $317 0.00% Unchanged
7 SBI Securities Co., Ltd. 0.00% of their portfolio TOKYO, M0 7575 $195 $195 0.00% Unchanged
8 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 6464 $166 $166 0.00% Unchanged
9 NewEdge Advisors, LLC 0.00% of their portfolio NEW ORLEANS, LA 1717 $44 $44 0.00% Unchanged
10 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 1010 $26 $26 0.00% Added +1 +1
11 CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio BIRMINGHAM, AL 00 $0 $0 — Unchanged